Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study

Conclusion
In hemodialysis patients with SHPT, dysregulated sMg is an important contributor to all-cause death. Further studies are warranted to examine whether or not correction of sMg improves survival.

Source: CKJ: Clinical Kidney Journal - November 20, 2015 Category: Urology & Nephrology Authors: Kurita, N., Akizawa, T., Fukagawa, M., Onishi, Y., Kurokawa, K., Fukuhara, S. Tags: CKD-MBD Source Type: research